These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 37128293)

  • 21. An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome.
    Kumari R; Kumar S; Kant R
    Diabetes Metab Syndr; 2019; 13(4):2409-2417. PubMed ID: 31405652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adipose tissue and its relation to inflammation: the role of adipokines.
    Axelsson J; Heimbürger O; Lindholm B; Stenvinkel P
    J Ren Nutr; 2005 Jan; 15(1):131-6. PubMed ID: 15648022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers.
    Koppe L; Fouque D; Kalantar-Zadeh K
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):479-484. PubMed ID: 30977979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipose tissue and inflammation in chronic kidney disease.
    Axelsson J; Heimbürger O; Stenvinkel P
    Contrib Nephrol; 2006; 151():165-174. PubMed ID: 16929140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adipokines: adiponectin, leptin, resistin and coronary heart disease risk].
    Kopff B; Jegier A
    Przegl Lek; 2005; 62 Suppl 3():69-72. PubMed ID: 16521924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White adipose tissue overproduces the lipid-mobilizing factor zinc α2-glycoprotein in chronic kidney disease.
    Pelletier CC; Koppe L; Croze ML; Kalbacher E; Vella RE; Guebre-Egziabher F; Géloën A; Badet L; Fouque D; Soulage CO
    Kidney Int; 2013 May; 83(5):878-86. PubMed ID: 23423258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The new adipose tissue and adipocytokines.
    Bulcão C; Ferreira SR; Giuffrida FM; Ribeiro-Filho FF
    Curr Diabetes Rev; 2006 Feb; 2(1):19-28. PubMed ID: 18220614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscle wasting and adipose tissue browning in infantile nephropathic cystinosis.
    Cheung WW; Cherqui S; Ding W; Esparza M; Zhou P; Shao J; Lieber RL; Mak RH
    J Cachexia Sarcopenia Muscle; 2016 May; 7(2):152-64. PubMed ID: 27493869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epicardial Adipose Tissue, Adiponectin and Leptin: A Potential Source of Cardiovascular Risk in Chronic Kidney Disease.
    D'Marco L; Puchades MJ; Gorriz JL; Romero-Parra M; Lima-Martínez M; Soto C; Bermúdez V; Raggi P
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipose tissue: an endocrine organ playing a role in metabolic regulation.
    Booth A; Magnuson A; Fouts J; Foster MT
    Horm Mol Biol Clin Investig; 2016 Apr; 26(1):25-42. PubMed ID: 26910750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia.
    Cheung WW; Zheng R; Hao S; Wang Z; Gonzalez A; Zhou P; Hoffman HM; Mak RH
    Sci Rep; 2021 Jul; 11(1):15141. PubMed ID: 34302016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adipokines in neurovascular diseases.
    Opatrilova R; Caprnda M; Kubatka P; Valentova V; Uramova S; Nosal V; Gaspar L; Zachar L; Mozos I; Petrovic D; Dragasek J; Filipova S; Büsselberg D; Zulli A; Rodrigo L; Kruzliak P; Krasnik V
    Biomed Pharmacother; 2018 Feb; 98():424-432. PubMed ID: 29278852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential dose effect of fish oil on inflammation and adipose tissue gene expression in chronic kidney disease patients.
    Guebre-Egziabher F; Debard C; Drai J; Denis L; Pesenti S; Bienvenu J; Vidal H; Laville M; Fouque D
    Nutrition; 2013 May; 29(5):730-6. PubMed ID: 23375525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipocytokines in Patients with Chronic Kidney Disease Stage 5.
    Yahya RS; Atwa MA; El-Sayed IH; El-Ghanaam DM; Hussein DT; El-Taweel FA
    Clin Lab; 2016; 62(1-2):21-30. PubMed ID: 27012030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased adipose tissue insulin resistance in metabolic syndrome: relationship to circulating adipokines.
    Adams-Huet B; Devaraj S; Siegel D; Jialal I
    Metab Syndr Relat Disord; 2014 Dec; 12(10):503-7. PubMed ID: 25162912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of adipokines in chronic inflammation.
    Mancuso P
    Immunotargets Ther; 2016; 5():47-56. PubMed ID: 27529061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance in patients with chronic kidney disease.
    Liao MT; Sung CC; Hung KC; Wu CC; Lo L; Lu KC
    J Biomed Biotechnol; 2012; 2012():691369. PubMed ID: 22919275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance in chronic kidney disease: a systematic review.
    Spoto B; Pisano A; Zoccali C
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1087-F1108. PubMed ID: 27707707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipogenic progenitors in different organs: Pathophysiological implications.
    Favaretto F; Bettini S; Busetto L; Milan G; Vettor R
    Rev Endocr Metab Disord; 2022 Feb; 23(1):71-85. PubMed ID: 34716543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.